Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karola Rittner

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Oncoimmunology|November 18, 2016
Vectorization in an oncolytic vaccinia virus of an antibody, a Fab and a scFv against programmed cell death -1 (PD-1) allows their intratumoral delivery and an improved tumor-growth inhibitionPatricia Kleinpeter, Laetitia Fend, Christine Thioudellet, et al.
Journal of Virology|February 28, 2014
Yeast virus-derived stimulator of the innate immune system augments the efficacy of virus vector-based immunotherapyMarie-Christine Claudepierre, Julie Hortelano, Emmanuelle Schaedler, et al.
Clinical & Translational Immunology|May 16, 2022
Pseudocowpox virus, a novel vector to enhance the therapeutic efficacy of antitumor vaccinationRodrigo Nalio Ramos, Caroline Tosch, Fiorella Kotsias, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Oncoimmunology|November 18, 2016
Vectorization in an oncolytic vaccinia virus of an antibody, a Fab and a scFv against programmed cell death -1 (PD-1) allows their intratumoral delivery and an improved tumor-growth inhibitionPatricia Kleinpeter, Laetitia Fend, Christine Thioudellet, et al.
Journal of Virology|February 28, 2014
Yeast virus-derived stimulator of the innate immune system augments the efficacy of virus vector-based immunotherapyMarie-Christine Claudepierre, Julie Hortelano, Emmanuelle Schaedler, et al.
Clinical & Translational Immunology|May 16, 2022
Pseudocowpox virus, a novel vector to enhance the therapeutic efficacy of antitumor vaccinationRodrigo Nalio Ramos, Caroline Tosch, Fiorella Kotsias, et al.
Pageof 2